‌

US Patent 10662213 Gemcitabine prodrugs

Patent 10662213 was granted and assigned to NuCana on May, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

NuCana

Current Assignee

NuCana

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10662213

Date of Patent

May 26, 2020

Patent Application Number

15308491

Date Filed

June 25, 2015

Patent Citations

‌

US Patent 10005810 Process for preparing nucleoside prodrugs

‌

US Patent 10117888 Formulation comprising a gemcitabine-prodrug

Patent Citations Received

‌

US Patent 11629164 Gemcitabine prodrugs

‌

US Patent 11414452 Synthesis of phosphate derivatives

Patent Primary Examiner

‌

Traviss C Mcintosh, III

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10662213 Gemcitabine prodrugs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API